מחיר חזוי לרווח: Silk Road Medical Inc. (SILK)

Silk Road Medical, Inc (SILK) operates on non-cyclical demand within vascular surgery, demonstrating high resilience to crises. The GURU.Markets terminal displays the company's expected price-to-earnings ratio, where the value 0.00 represents the current level of the metric. TCAR technology has become the gold standard for minimally invasive carotid artery treatment, and the acquisition by the Medtronic behemoth confirmed the systems' leadership and eliminated development risks.
פילוחי מדדים ואנליטיקה של חברת Silk Road Medical (SILK)

The forward P/E dynamics of Silk Road Medical, Inc (SILK) reflect market expectations for profits from the sale of TCAR systems for carotid artery treatment, accounting for insurance reimbursements. This indicator, calculated as the ratio of market capitalization to projected income adjusted for WACC, allows for an assessment of the asset's overvaluation or the risk of future free cash flow reduction.